Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine
Diabetic cardiomyopathy (DCM) is one of the common diabetic microangiopathy in clinical practice. In the early stage of the disease, there are no obvious clinical symptoms. In the middle and late stages, MF, arrhythmia, and even heart failure may occur, affecting the life and health of patients. MF,...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1523014/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832585020347252736 |
---|---|
author | Bin Wan Jing Hu Yue Luo Yutong Han Yaowen Zhang Qinchuan Huang Yulin Leng Chunguang Xie Chunguang Xie |
author_facet | Bin Wan Jing Hu Yue Luo Yutong Han Yaowen Zhang Qinchuan Huang Yulin Leng Chunguang Xie Chunguang Xie |
author_sort | Bin Wan |
collection | DOAJ |
description | Diabetic cardiomyopathy (DCM) is one of the common diabetic microangiopathy in clinical practice. In the early stage of the disease, there are no obvious clinical symptoms. In the middle and late stages, MF, arrhythmia, and even heart failure may occur, affecting the life and health of patients. MF, as one of the pathological features of DCM at the end stage, is the key factor of poor prognosis leading to ventricular wall stiffness and heart failure, which affects the clinical process and outcome of patients. The development of MF in a high glucose environment involves multiple complex fibrogenic pathways that work together to activate fibroblasts, thereby promoting MF. Indeed, aberrant activation of cardiac fibroblasts (CFs) is a key factor in MF. Therefore, inhibiting the activation of CFs may become a new strategy for the treatment of DCM. Previous studies have shown that Chinese herbal medicine (CHM) has potential in the treatment of DCM. In this review, we first introduced the physiology and function of CFs and discussed the conditions for the pathological activation of CFs in the process of diabetes, and then systematically summarized the effects of CHM on the activation of CFs by controlling the production of advanced glycosylation end products, oxidative stress and inflammation. This review will illustrate the potential of CHM to inhibit the activation of CFs and provide new ideas for the treatment of DCM. |
format | Article |
id | doaj-art-b991719f04824482905c3278ea5180f5 |
institution | Kabale University |
issn | 1663-9812 |
language | English |
publishDate | 2025-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj-art-b991719f04824482905c3278ea5180f52025-01-27T06:40:59ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011610.3389/fphar.2025.15230141523014Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicineBin Wan0Jing Hu1Yue Luo2Yutong Han3Yaowen Zhang4Qinchuan Huang5Yulin Leng6Chunguang Xie7Chunguang Xie8Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaChengdu University of Traditional Chinese Medicine, Chengdu, ChinaChengdu University of Traditional Chinese Medicine, Chengdu, ChinaChengdu University of Traditional Chinese Medicine, Chengdu, ChinaChengdu University of Traditional Chinese Medicine, Chengdu, ChinaChengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaTCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDiabetic cardiomyopathy (DCM) is one of the common diabetic microangiopathy in clinical practice. In the early stage of the disease, there are no obvious clinical symptoms. In the middle and late stages, MF, arrhythmia, and even heart failure may occur, affecting the life and health of patients. MF, as one of the pathological features of DCM at the end stage, is the key factor of poor prognosis leading to ventricular wall stiffness and heart failure, which affects the clinical process and outcome of patients. The development of MF in a high glucose environment involves multiple complex fibrogenic pathways that work together to activate fibroblasts, thereby promoting MF. Indeed, aberrant activation of cardiac fibroblasts (CFs) is a key factor in MF. Therefore, inhibiting the activation of CFs may become a new strategy for the treatment of DCM. Previous studies have shown that Chinese herbal medicine (CHM) has potential in the treatment of DCM. In this review, we first introduced the physiology and function of CFs and discussed the conditions for the pathological activation of CFs in the process of diabetes, and then systematically summarized the effects of CHM on the activation of CFs by controlling the production of advanced glycosylation end products, oxidative stress and inflammation. This review will illustrate the potential of CHM to inhibit the activation of CFs and provide new ideas for the treatment of DCM.https://www.frontiersin.org/articles/10.3389/fphar.2025.1523014/fulldiabetic cardiomyopathyChinese herbal medicinemyocardial fibrosiscardiac fibroblastsmechanism of action |
spellingShingle | Bin Wan Jing Hu Yue Luo Yutong Han Yaowen Zhang Qinchuan Huang Yulin Leng Chunguang Xie Chunguang Xie Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine Frontiers in Pharmacology diabetic cardiomyopathy Chinese herbal medicine myocardial fibrosis cardiac fibroblasts mechanism of action |
title | Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine |
title_full | Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine |
title_fullStr | Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine |
title_full_unstemmed | Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine |
title_short | Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine |
title_sort | inhibition of high glucose induced cardiac fibroblast activation an effective treatment for diabetic cardiomyopathy using chinese herbal medicine |
topic | diabetic cardiomyopathy Chinese herbal medicine myocardial fibrosis cardiac fibroblasts mechanism of action |
url | https://www.frontiersin.org/articles/10.3389/fphar.2025.1523014/full |
work_keys_str_mv | AT binwan inhibitionofhighglucoseinducedcardiacfibroblastactivationaneffectivetreatmentfordiabeticcardiomyopathyusingchineseherbalmedicine AT jinghu inhibitionofhighglucoseinducedcardiacfibroblastactivationaneffectivetreatmentfordiabeticcardiomyopathyusingchineseherbalmedicine AT yueluo inhibitionofhighglucoseinducedcardiacfibroblastactivationaneffectivetreatmentfordiabeticcardiomyopathyusingchineseherbalmedicine AT yutonghan inhibitionofhighglucoseinducedcardiacfibroblastactivationaneffectivetreatmentfordiabeticcardiomyopathyusingchineseherbalmedicine AT yaowenzhang inhibitionofhighglucoseinducedcardiacfibroblastactivationaneffectivetreatmentfordiabeticcardiomyopathyusingchineseherbalmedicine AT qinchuanhuang inhibitionofhighglucoseinducedcardiacfibroblastactivationaneffectivetreatmentfordiabeticcardiomyopathyusingchineseherbalmedicine AT yulinleng inhibitionofhighglucoseinducedcardiacfibroblastactivationaneffectivetreatmentfordiabeticcardiomyopathyusingchineseherbalmedicine AT chunguangxie inhibitionofhighglucoseinducedcardiacfibroblastactivationaneffectivetreatmentfordiabeticcardiomyopathyusingchineseherbalmedicine AT chunguangxie inhibitionofhighglucoseinducedcardiacfibroblastactivationaneffectivetreatmentfordiabeticcardiomyopathyusingchineseherbalmedicine |